Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-mesothelin (CRS-207) With or Without Nivolumab in Patients with Pancreatic Cancer

PURPOSE: Two studies in previously-treated metastatic pancreatic cancer have been completed combining GVAX pancreas vaccine (granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cells) with cyclophosphamide (Cy) and CRS-207 (live, attenuated Listeria monocytogenes e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Tsujikawa, Takahiro, Crocenzi, Todd, Durham, Jennifer N., Sugar, Elizabeth, Wu, Annie A., Onners, Beth, Nauroth, Julie M., Anders, Robert A., Fertig, Elana J., Laheru, Daniel A., Reiss, Kim A., Vonderheide, Robert H., Ko, Andrew H., Tempero, Margaret A., Fisher, George A., Considine, Michael, Danilova, Ludmila, Brockstedt, Dirk G., Coussens, Lisa M., Jaffee, Elizabeth M., Le, Dung T.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727397/
https://ncbi.nlm.nih.gov/pubmed/32273276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3978
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares